Plus, the Nevada court battle over the future of Rupert Murdoch’s empire and how a corporate lawyer won gold at the Paralympics
Philip Morris pivot from tobacco to healthcare with purchase of Vectura sparked opposition from doctors
Popular alternative to traditional cigarettes faces EU flavouring ban and US approval delays
The real American ‘superstonks’
Soaring sales of flavoured nicotine pouches catch attention of US politicians and regulators
Dissecting the claim that responsible investors should consider a fiercely criticised sector
The tobacco company can justifiably claim expertise in developing alternative products that smokers will actually try
Jacek Olczak argues that shift away from cigarettes should prompt a rethink after wave of exclusionary policies
Owner of the Marlboro brand in the US seeks to double revenues from smokeless products
Jacek Olczak says he is steering the tobacco group away from cigarettes towards ‘healthy solutions’
Company signals ‘no hope’ of a deal because of Kremlin terms on foreign companies’ asset sales
Activist hedge fund stands to make about $150mn in profit from deal
Hedge fund now has power to decide outcome of Philip Morris International’s $16bn offer for smokeless tobacco specialist
Cigarette maker bows to pressure from activist funds that have built stakes in smokeless tobacco specialist
Segment carries lower regulatory risk than traditional cigarettes
Even if its $16bn investment in Swedish Match disappoints, annual cigarette sales of 600bn provide decent insurance
Acquisition takes company further into market for tobacco-free alternatives to cigarettes
European group’s success with chewing tobacco and pouches make for a tidy addition
Marlboro seller close to acquisition of maker of snus tobacco pouches in further shift away from cigarettes
Companies turn to share buybacks as investors ditch stocks over ESG concerns
Chief executive Jacek Olczak tells FT that chapter involving fellow tobacco group is ‘closed’
Japanese pharma company says Medicago’s product will be cheaper to make and easier to transport
Cigarette maker secures majority of shares in UK-based medical device manufacturer
Shareholders in UK inhaler maker will have final say in a takeover battle that has divided opinion
We must allow companies to reinvent themselves and address the problems they helped create
